Elevated calcitonin and procalcitonin levels in nonmedullary benign and malignant thyroid nodules.


Background. To evaluate the elevation rate of serum markers calcitonin (CT) and procalcitonin (ProCT) in patients with non-medullary benign and malignant thyroid nodules. Methods. Before surgery CT and ProCT were measured in sera from 168 patients with histologically proven benign thyroid nodules (n=107) and non-medullary thyroid carcinomas (n=61). Sera… (More)
DOI: 10.1111/j.1365-2265.2009.03733.x

3 Figures and Tables


  • Presentations referencing similar topics